CVE-2022-36180Fusiondirectory 1.3 is vulnerable to Cross Site Scripting (XSS) via /fusiondirectory/index.php?message=[injection],…
- 9.6CriticalCVSS base score
- 0.94%Exploitation in 30 daysEPSS · top 38% of all CVEs
- NoKnown exploitednot in CISA's KEV catalog
- YesPublic exploitsa reference or SSVC says so
Description
Fusiondirectory 1.3 is vulnerable to Cross Site Scripting (XSS) via /fusiondirectory/index.php?message=[injection], /fusiondirectory/index.php?message=invalidparameter&plug={Injection], /fusiondirectory/index.php?signout=1&message=[injection]&plug=106.
Public exploit
An exploit or proof of concept is public: anyone can try it against an unpatched system. CISA's SSVC rates its exploitation: a proof of concept is public.
Timeline
ID reserved
By mitre
- 4 months later
· 4 months later
Published
- 4 years later
· 4 years later
Record updated
Changes after publication (a new score, a public exploit, EPSS crossing 1, 10 or 50 %, leaving KEV) are kept since November 2026; earlier ones are not known.
Scores
| Scored by | CVSS | Score | Vector |
|---|---|---|---|
| CISA-ADPADP (enrichment) | 3.1 | Critical9.6 | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H |
| NVDNVD · Modified | 3.1 | Critical9.6 | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H |
- EPSS (exploitation in 30 days)
- 0.94% · top 38% of all CVEs (18 Nov 2026)
- CISA SSVC
- Exploitation: poc · Automatable: no · Technical impact: total
The list uses the assigner's score when there is one, then CISA's, then NVD's: Critical 9.6.
Affected products
n/a
- affected n/a
References
Sources
The same CVE in the primary databases and aggregators, to check against.
- CVE.org record (opens in a new tab)
- CVE List JSON (GitHub) (opens in a new tab)
- NVD (opens in a new tab)
- FIRST EPSS (opens in a new tab)
- EUVD EUVD-2022-38900 (opens in a new tab)
- OSV.dev (opens in a new tab)
- GitHub Advisories (opens in a new tab)
- CIRCL Vulnerability-Lookup (opens in a new tab)
Badge for a README or a ticket
[](https://cveledger.app/cve/CVE-2022-36180)Record last updated .